Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

At ASM Microbe, Attention on Reimbursement and Drug-Resistant Pathogens

Luminex workshop offered a look at flexible molecular testing for GI cases

We’re finally recovering from the whirlwind that is ASM Microbe, the annual mega-conference of the American Society for Microbiology. This year, the event took place in sunny San Francisco, bringing thousands of microbial experts together to discuss the latest advances and challenges in this field.

Continue Reading >

Using Luminex to Help Treat Respiratory Patients



Dr. Gonzalez is a family practitioner who treats an eclectic mix of patients, young and old. He runs a smart practice and knows the value of syndromic testing as well as when a targeted approach makes better sense, especially when testing for a potential respiratory illness. Watch how he works to strategically treat two types of patients with respiratory infections.

Watch more videos >

Luminex on Twitter

RT @IDSAInfo: Urinary tract infections "are the single biggest risk to healthy people from drug-resistant germs." #…
h J R
It wasn't difficult to spot a spike in interest in 𝘊. 𝘥𝘪𝘧𝘧𝘪𝘤𝘪𝘭𝘦 infections at this year's #ASMicrobe. What else cau…
h J R
Do you #multiplex? Then sign up for #xMAPConnect, the premier multiplex users' group meeting, hitting San Diego Oct…
h J R

Latest News

July 1
Luminex Submits ARIES MRSA Assay for FDA Clearance

May 21
Luminex Corporation Declares Second Quarter Cash Dividend

May 14
Luminex Corporation to Present at Upcoming Healthcare Investor Conferences

May 6
Luminex Corporation Reports First Quarter 2019 Financial Results

April 18
Luminex Corporation First Quarter Earnings Release Scheduled for May 6, 2019


AACC Annual Meeting & Clinical Lab Expo
August 6-8
Anaheim, CA

October 2-6
Washington, D.C.

xMAP® Connect San Diego
October 3
San Diego, CA